Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07269548Recruiting
Healing of pilonidal cyst after 1940 nm laser treatment
This study checks how well a pilonidal cyst heals after treatment with a special laser (1940 nm). It looks at your recovery after the surgery to see if the laser helps the wound close properly.
LyonAges 18 years+ - NCT07269782RecruitingPhase 2
Pre-surgery treatment for stage II-III lung cancer
This study tests two investigational drugs (HLX43 and serplulimab) given before surgery to people with stage II to III non-small cell lung cancer (NSCLC). The goal is to see if these drugs can shrink the tumor and make it easier to remove completely during surgery.
ShanghaiAges 18–75 - NCT07270003Recruiting
Ivarmacitinib for palmoplantar pustulosis
This trial tests a new oral medication, ivarmacitinib, for adults with palmoplantar pustulosis (PPP) who haven't gotten better with standard treatments. It aims to see if the drug is safe and effective for reducing the painful pustules on the palms and soles.
Xi'an, ShaanxiAges 18 years+ - NCT07272395Recruiting
Heart function changes after pacemaker or ICD placement
This study looks at how heart devices (pacemakers, ICDs, or CRT devices) affect the right side of the heart. Participants will have imaging tests before and after the device is placed to see how the heart functions.
Istanbul, FATIHAges 18 years+ - NCT07273773Recruiting
Evaluating a new inflatable penile implant for erectile dysfunction
This trial tests a device called the Infla10®, an inflatable penile implant for men with erectile dysfunction. The goal is to see how well it works and how safe it is.
Coral Gables, FloridaAges 22 years+ - NCT07273812Recruiting
AI phone app to help with chemotherapy side effects in breast cancer
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
BaghdadAges 18 years+ - NCT07273994RecruitingPhase 4
Comparing two amiodarone doses after heart shock treatment for atrial fibrillation
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
BarcelonaAges 18 years+ - NCT07275879Recruiting
Quality of life with a new ureteral stent
This study tests a modified double J stent to see how it affects your quality of life. If you have kidney or ureter stones, this trial may help improve comfort during treatment.
Saint Petersburg, Outside U.S./CanadaAges 18 years+ - NCT07278518Recruiting
Emergency department decision aid for buprenorphine
This trial is testing a tool to help people in the emergency department decide whether to start buprenorphine (a medication for opioid use disorder). It's for patients who are not already on medication for their condition.
Charleston, South CarolinaAges 18 years+ - NCT07278921Recruiting
Mosunetuzumab for relapsed follicular lymphoma
This trial tests a drug called Mosunetuzumab for people with follicular lymphoma that has come back or stopped responding after at least two previous treatments. It is available through a compassionate use program for those who have no other options.
MilanAges 18 years+ - NCT07279688RecruitingPhase 3
Baricitinib plus steroids for polymyalgia rheumatica
This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.
Aix-en-ProvenceAges 50 years+ - NCT07280247Recruiting
AlphaVac System for Treating Acute Pulmonary Embolism
This study tests a device that suctions blood clots from the lungs in people with a moderate-risk pulmonary embolism. The goal is to see if it is safe and effective at removing clots and improving blood flow.
Saint Cloud, MinnesotaAges 18 years+ - NCT07280312Recruiting
Ultrasound imaging test for ovarian lesions
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
Rochester, MinnesotaAges 18 years+ - NCT07281287Recruiting
Study of financial help for cancer patients at UAB clinic
This trial looks at how well a program that helps cancer patients with money and insurance issues works. It may help you if you are treated at UAB's Medical Oncology clinic and want to understand how financial support affects your care.
Birmingham, AlabamaAges 18 years+ - NCT07281703RecruitingPhase 1
Safety study of HY8931 in healthy adults
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
BrisbaneAges 18–45 - NCT07282756Recruiting
Lovastatin gel for gum disease treatment
This study tests whether a lovastatin gel applied to the gums (after a deep cleaning) helps treat gum disease better than cleaning alone. Participants must not have had previous gum treatment or antibiotics recently, and can be a smoker or non-smoker.
Bielsko-Biala, Silesian VoivodeshipAges 18–59 - NCT07283042Recruiting
Studying a new way to classify placenta conditions
This trial tests a new classification system for placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. It aims to see if this system helps predict outcomes and improve care for pregnant people who need surgery for PAS.
Los Angeles, CaliforniaAges 18–55 - NCT07283185Recruiting
Comparing the carbon footprint of EUS and MRCP for bile duct stones
This trial compares the environmental impact of two common tests for bile duct stones: endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP). It aims to find out which test has a smaller carbon footprint while still being effective.
Hyderabad, TelanganaAges 18–80 - NCT07283263RecruitingPhase 1
Safety study of new drug BMS-986521 in healthy volunteers
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
Anaheim, CaliforniaAges 18–80 - NCT07283809Recruiting
Heart care study for patients with common heart problems
This study is collecting information about people with common heart conditions to help doctors learn how to offer better care. If you have had a heart attack, heart failure, or atrial fibrillation, your experience can help improve treatment for others.
Montevarchi, AREZZOAges 18 years+ - NCT07284121Recruiting
Patient satisfaction and safety of Atezolizumab in routine care
This study tracks how well Atezolizumab (Tecentriq) works for people with certain lung or liver cancers in everyday medical practice. It helps doctors understand if patients are satisfied with their treatment and how it affects their quality of life.
KremsAges 18 years+ - NCT07284797RecruitingPhase 1
Safety study for autoimmune disease and healthy volunteers
This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.
MelbourneAges 18–75 - NCT07285356Recruiting
Surgical gloves to prevent nerve damage from oxaliplatin
This trial tests whether wearing special surgical gloves during oxaliplatin chemotherapy can help prevent nerve damage (numbness or tingling) in people with advanced colon cancer.
São Paulo, São PauloAges 18 years+ - NCT07285590RecruitingPhase 2
Testing pirtobrutinib and rituximab for mantle cell lymphoma
This trial tests a new drug combination (pirtobrutinib plus rituximab) for people with mantle cell lymphoma who have not yet received any treatment and do not have symptoms. The goal is to see if the combination is safe and effective.
Lisbon, Lisbon DistrictAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.